Robert Mears, an officer of Atomera Inc (ATOM), gave notice of a proposed sale of 1,000 common shares, with an estimated aggregate market value of $4,380.00 and an approximate sale date of October 1, 2026. Morgan Stanley Smith Barney LLC is identified as the broker. The reported history also lists four sales by Mears during the preceding three months.
Atomera Inc (ATOM) reported that its chief financial officer, Laurencio Francis, sold a total of 6,504 shares of common stock on September 1, 2026 at $4.05 per share in open-market or private transactions. According to the disclosure, all shares were sold solely to cover mandatory tax withholding obligations arising from the vesting of previously reported restricted stock grants through a "sell to cover" transaction carried out under a Rule 10b5-1 trading plan.
Atomera Inc (ATOM) reported that its Chief Technology Officer, Robert J. Mears, sold a total of 12,679 shares of common stock on September 1–2, 2026, at prices of $4.05 and $3.87 per share. All reported sales were effected under Rule 10b5-1 trading arrangements, and a portion of the shares was sold solely to cover tax withholding obligations arising from vested restricted stock grants. As of September 1, 2026, 2,666 shares of Atomera common stock were held indirectly through Mears’ spouse.
Atomera Inc (ATOM) disclosed that CEO and President Scott A. Bibaud sold a total of 13,756 shares of common stock on September 1, 2026 at $4.05 per share in four open-market transactions. According to the company’s disclosure, these were "sell to cover" sales to satisfy mandatory tax withholding on previously reported restricted stock vesting, executed pursuant to a Rule 10b5-1 trading plan.
Atomera Inc (ATOM) reports that officer Robert J. Mears6,312 shares
The filing also details multiple common‑stock sales by Mears over the prior three months, including several large June transactions and additional sales in July, August, and September 2026, indicating ongoing liquidity activity by this insider.
Atomera Inc (ATOM) received a Form 144 notice from Chief Technology Officer Robert Mears covering a planned sale of 5,367 shares of common stock on 09/01/2026, following the vesting of restricted stock. The shares are to be sold through Morgan Stanley Smith Barney LLC under the issuer’s equity compensation plan. Over the prior three months, Mears reported multiple sales of Atomera common stock, and the filing states these are non-discretionary “sell-to-cover” transactions executed under Rule 10b5-1 trading arrangements for tax or withholding purposes.
Atomera Inc (ATOM) received a notice under Rule 144 that its Chief Financial Officer, Francis Laurencio, plans to sell 6,504 shares of common stock. The shares relate to the vesting of restricted stock on 09/01/2026 and were granted under Atomera’s equity compensation plan.
The filing states the transactions are non‑discretionary “sell to cover” sales under four separate equity awards dated 02/23/2023, 02/21/2024, 02/19/2025 and 03/02/2026, each structured as a Rule 10b5‑1 trading arrangement. Laurencio also sold 20,400 shares in the prior three months on 06/15/2026.
Atomera Inc (ATOM) reports that its CEO, Scott Bibaud, has filed a Form 144 indicating an intention to sell up to 13,756 shares of common stock, with an aggregate market value of $55,706.87, through Morgan Stanley Smith Barney LLC, with an approximate sale date of September 1, 2026. These shares are tied to the vesting of restricted stock granted under Atomera’s equity compensation plan and are described as non-discretionary “sell-to-cover” transactions under Rule 10b5-1 trading arrangements. Over the prior three months, Bibaud reported selling 50,000 shares for $468,293.90.
Atomera Inc (ATOM) received a Rule 144 notice from officer Robert Mears covering a proposed sale of 1,000 shares of common stock through Morgan Stanley Smith Barney on NASDAQ, with an aggregate market value of $4,050.00. The notice also lists multiple prior sales of Atomera common stock by Mears during the past three months.
Atomera Incorporated, an early-stage semiconductor technology licensing company, reported minimal revenue and continued losses for the quarter ended June 30, 2026. Revenue was $158 thousand for the quarter and $169 thousand for the first half of 2026, compared with $0 and $4 thousand in the prior-year periods. Net loss was $6,336 thousand for the quarter and $12,409 thousand year-to-date, with basic and diluted net loss per share of $0.17 and $0.34, respectively.
Operating expenses rose to $6,891 thousand in the quarter and $13,100 thousand for the first half, driven by higher research and development, general and administrative, and selling and marketing costs, including increased bonus accruals, stock-based compensation and patent-related legal expenses. Stock-based compensation totaled $3,147 thousand in the first half, and the company expanded its equity programs with new performance-based stock options and restricted stock units.
Liquidity strengthened through equity financing. As of June 30, 2026, Atomera held approximately $38.4 million in cash, cash equivalents and short-term investments and working capital of approximately $36.7 million. During the first half, it raised about $23.6 million via a registered direct offering of 5,000,000 shares at $5.00 per share and approximately $3.1 million through sales under a $50.0 million at-the-market facility. Net cash used in operating activities was $8,504 thousand for the first half of 2026, and management states that available capital is sufficient to fund current plans and obligations for at least 12 months.